| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Organon Mid-Europe (France, Belgium, Luxemburg, Switzerland) France, Belgium, Luxemburg, Switzerland. One Team for better & healthier every day for every woman. Organon, here for her health We are a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established brands across a wide array of conditions and diseases. For more information, visit www.organon.fr or follow us on https://twitter.com/OrganonFrance Type: | 10 | 3 | 8 | 113 |
 | Big4Bio Your daily digest of life science developments in the top bioclusters in the world. The life sciences sector is witnessing unprecedented levels of innovation and investment, while the health care industry as a whole is in the midst of a sea change. If you aren’t a full-time analyst, how can you keep up and find the key information you need to make the right decisions for your business? That’s where we come in. Big4Bio is the premier life sciences aggregator of financial, clinical, and business news. Our free, daily emails give you easy-to-scan headlines on key developments and links to … Type: | 16 | 0 | 15 | 11 |
 | AusBiotech Australia's Biotechnology Organisation AusBiotech is Australia's Biotechnology Industry Organisation, which represents over 3,000 members working in life sciences, including therapeutics, medical technology (devices and diagnostics), digital health, food technology and agricultural sectors. AusBiotech is dedicated to the development, growth and prosperity of the Australian Biotechnology Industry, by providing initiatives to drive sustainability and growth, outreach and access to markets, and representation and support for members nationally and around the world. AusBiotech has representation in each Australian state providing a national network to support members and promote the commercialisation of Australian bioscience in the national and international marketplaces. The structure is … Type: | 23 | 5 | 17 | 62 |
 | McDonnell Boehnen Hulbert & Berghoff LLP Intellectual Property Law: Up to Speed. Down to Earth. At MBHB, the legal and scientific credentials of our professionals are first rate. Period. We speak the languages of law and science—and of the people we serve. One hundred percent of MBHB’s attorneys and technical advisors hold science or engineering degrees. Of these, nearly 50% of our attorneys and technical advisors hold Ph.D.s or other advanced degrees. We’re “up to speed” on the science and technology involved in IP law. But we’re also very “down to earth” in the way we choose to run our firm. As an intellectual property law … | 10 | 0 | 9 | 127 |
 | Prince Edward Island BioAlliance Coordinating the cluster of organizations dedicated to increasing the economic impact of the bioscience sector in PEI. The Prince Edward Island BioAlliance is the private sector-led not-for-profit organization that is responsible for developing and coordinating the strategy for the growth of the Prince Edward Island Bioscience Cluster. Since 2005, the BioAlliance has facilitated the work of businesses, academic and research institutions, and federal and provincial government agencies in establishing the bioscience sector as a key pillar in the economic foundation of the province and Atlantic Canada. Building from plans developed since 2005, the collaborative model of the BioAlliance has enabled … Type: | 5 | 0 | 3 | 8 |
 | Emergence Atlantic Canada's Bioscience Business Incubator Emergence is a business incubator dedicated to assisting start-ups and growth stage bioscience companies in efficiently bringing their products and services to market. Emergence clients benefit from access to business, technical, scientific and regulatory support services customized to meet their individual needs. This includes one-on-one and team-based mentorship; third-party consulting services; market research; legal, IP, insurance, tax and financial expertise from a network of professional service provider partners; and support accessing international networks and public and private funding and investment opportunities. Emergence serves high-potential companies wherever they are located in Canada, while also providing a … Type: | 4 | 0 | 3 | 3 |
 | KEZAD Group Khalifa Economic Zones Abu Dhabi KEZAD Group (Khalifa Economic Zones Abu Dhabi) is the UAE's largest operator of fully-integrated economic zones and value added business services, staff accommodation and industrial real estate solutions. Committed to creating competitive business ecosystems that encourage unprecedented growth, KEZAD Group is a key enabler of Abu Dhabi’s vision for the diversification of its economy. The Group helps build an open, agile and integrated business environment that attracts foreign and local investments to Abu Dhabi by offering outstanding market access, lower operating costs, and ease of doing business both in the region and globally. KEZAD Group's … Type: | 5 | 1 | 4 | 132 |
 | Future Fields We use fruit flies to help scientists change the world. Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngineTM, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science. Future Fields is a proud business member of 1% for the Planet, a … Type: | 6 | 0 | 5 | 43 |
 | Barinthus Biotherapeutics Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates. Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of … Type: | 12 | 4 | 6 | 119 |
 | Syngulon Original genetic technologies using bacteriocins. Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. Our team of scientists works in different academic laboratories and our R&D programs involve partners from Belgium, Spain, France, Switzerland, The Netherlands, and the UK. We think of ourselves as a “Startup in the Labs”, meaning that we work directly in the labs of our academic partners. The members of our Scientific Advisory Board are active in Belgium, France and the USA. The mission of Syngulon is to provide genetic technologies that make microbial strains involved in industrial processes safer and more efficient. … Type: | 5 | 2 | 2 | 9 |
 | Solve ME/CFS Initiative Working to make ME/CFS widely understood, diagnosable, and treatable. #SolveME #MECFS Donate: solvecfs.org/donate/ Solve M.E. is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other infection-associated chronic conditions and illnesses (IACCIs). Our work with the scientific, medical, and pharmaceutical communities, advocacy with government agencies, and alliances with patient groups around the world are laying the foundation for breakthroughs that can improve the lives of millions who suffer from various “long haul” diseases. Follow our page to stay up to date on the latest … Type: | 2 | 1 | 1 | 29 |
 | Kezar Life Sciences Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be … Type: | 1 | 1 | 0 | 71 |
 | Space Tango Unearth Answers in Microgravity for Humanity Space Tango is an industry leader in automated systems in the pursuit of health and technology manufacturing in space. Since 2017 through a NASA Space Act Agreement, Space Tango provides facilities to support iterative R&D and manufacturing in space. Through an integrated and intuitive approach, Space Tango works alongside its diverse partner base to embrace pathways to on-orbit production yielding valuable and transformational solutions for humanity. Space Tango believes the microgravity environment is a new frontier for discovery and innovation. We are focused on creating a new global market 250 miles up in low … Type: | 2 | 2 | 0 | 30 |
 | Aequor A Group of Companies - Global IT/Staffing, Healthcare/Clinical/Therapy, Education/Finance, S/W Solutions & Consulting. Since 1998, Aequor has provided exceptional workforce staffing services in multiple industries. Specializing in healthcare, we place nurses, therapists, allied professionals, physicians and medical technicians, as well as staff in the life sciences, technologies and schools. We believe in making a positive impact in the lives of those we serve by inspiring people and empowering growth both personally and professionally, which makes us better as individuals and as a company. We teach our team members to nurture positive and supportive relationships with our clients and candidates by … Type: | 1 | 1 | 0 | 447 |
 |  The Bayh-Dole Coalition Research and scientific organizations committed to protecting the Bayh-Dole Act and educating policymakers about it. The Bayh-Dole Coalition is a diverse group of research and scientific organizations, as well as those directly involved in commercializing new products, committed to protecting the Bayh-Dole Act and educating policymakers about the positive impacts of the law. Type: | 1 | 1 | 0 | 2 |
 | LifeScience WorldWide LifeScience & Biotech Worldwide Biotech Developments Type: | 14 | 0 | 14 | 1 |
 | TILT Biotherapeutics Ltd To make T-cells kill cancer, TILT is the answer TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his … Type: | 4 | 0 | 4 | 24 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 44 | 16 | 31 | 182 |
 |  MaaT Pharma The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process … Type: | 36 | 14 | 31 | 82 |
 | Voxcan Animal Medical Imaging Services Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcan’s core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBC's 3R policy and … Type: | 6 | 1 | 5 | 16 |
 | Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense-JPEO-CBRND JPEO-CBRND: Providing the warfighter with the best CBRN defense technology, equipment and medical countermeasures Welcome to the official Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) LinkedIn page. Our mission is to provide the warfighter with the best CBRN defense technology, equipment, and medical countermeasures at the right cost, at the right time, and at the right place. For more information, visit https://www.jpeocbrnd.osd.mil/ MISSION Provide integrated layered Chemical, Biological, Radiological, and Nuclear defense capabilities to the Joint Force across warfighting functions and combined Joint All-Domain Operations VISION A resilient Joint Force enabled to fight and win … Type: | 5 | 0 | 4 | 187 |
 | Ultragenyx Going Beyond Every Day Leading with purpose. Every day. “Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.” Emil D. Kakkis, M.D., Ph.D. Chief Executive Officer and President We have an inclusive culture of value and … Type: | 7 | 0 | 3 | 1,489 |
 | EnteroBiotix Mastering the microbiome, transforming lives® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome. Type: | 1 | 0 | 1 | 53 |
 | Dalan Animal Health, Inc. We bring the world transformative animal health solutions supporting a more sustainable future. Dalan's novel platform technology has introduced the world's first-ever honeybee vaccine, marking a pivotal milestone for the industry. Our mission is to safeguard the planet’s most underserved animal species, ensuring their continued well-being for global food security and the overall health of our planet. Type: | 1 | 0 | 1 | 25 |
 | AMR Industry Alliance The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance. The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure the life-sciences’ industry progress to curb #AMR. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measures industry’s progress in the fight against antimicrobial resistance. A first progress report was launched in January 2018, and tracked progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify … Type: | 12 | 2 | 7 | 12 |
 | Carthera Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical … Type: | 31 | 11 | 20 | 29 |
 | Epigene Labs augmented intelligence for precision oncology research and drug development Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies. Type: | 10 | 4 | 7 | 33 |
 | Smart Immune Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T … Type: | 24 | 12 | 14 | 36 |
 | mYXpression Digital bio-solutions designed to support the development of biomedicines and optimize their prescription. mYXpression is an innovative French company positioned in the field of health innovation. The company, specialized in R&D, develops innovative tools to assist in the prescription of biomedicines. Its first tool, the RITI® RA test, provides a personalized report specific to the patient by indicating an efficacy score for each biotherapy. This brand new approach provides numerous useful insights to the doctor by assisting in the prescription of biotherapy in order to increase the patient's chances of remission. bio-numérique, innovation technologique, big data, bio-technologie , biotherapie, intelligence … Type: | 22 | 4 | 21 | 5 |
 | Evexta Bio Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in … Type: | 6 | 0 | 6 | 13 |
 | Oncofactory 🖇️ Oncofactory, a spin-off of the CNRS, is a science-driven biotech company that provides pharmaceutical and biotech companies with innovative in vivo services to support their non-clinical programs in oncology. Oncofactory joined the ERBC Group in December 2022 to extend its technology to a wider range of customers and provide a one-stop shop for non-clinical studies. 🥚Oncofactory unique technology platform is a New Approach Methodology (NAM) to generate patient tumor replicas in avian embryos (AVI-PDXTM), coupled with state-of-the-art 3D imaging and large-scale molecular analysis for rapid assessment of therapeutic efficacy and in-depth characterization of mechanisms of action to evaluate therapeutic … Type: | 5 | 1 | 4 | 8 |
 | Delaware Prosperity Partnership Delaware Prosperity Partnership (DPP) attracts, grows & retains businesses and strengthens the innovation ecosystem. The Delaware Prosperity Partnership (DPP) team is committed to supporting companies who want to grow or locate their company in Delaware. We also support building a stronger entrepreneurial and innovation ecosystem and private employers in identifying, recruiting and developing talent in Delaware. What We Do: The DPP team makes it easy for you to do business in Delaware. Whether you’re a site selector or advisor, commercial real estate developer, or C-Suite executive decision maker responsible for reviewing optimal sites to establish, expand, or relocate your company, … Type: | 10 | 2 | 7 | 19 |
 | Vivani Vivani Medical is a pre-clinical-stage developer of long-term pharmaceutical implants aimed at revolutionizing the treatment of patients with chronic diseases. Leveraging its proprietary NanoPortalTM platform, Vivani’s portfolio of tiny, sub-dermal drug implants address medication non-adherence by providing steady levels of medication over a target duration of six months or longer. Vivani is developing two miniature, long-term GLP-1 implants for the treatment of obesity and chronic weight management: NPM-115 (exenatide) and NPM-139 (semaglutide). In addition, the company is developing NPM-119, a lower dose exenatide implant for the treatment of type 2 diabetes. Type: | 4 | 1 | 3 | 31 |
 | Wallonia.be/fr [Automatic translation follows] Feel inspired Official portal of Wallonia internationally Wallonia.be Wallonia: An open region, a land of exchanges Wallonia is a region naturally open to the world, where languages and cultures dialogue. An export vocation. An extraordinary sense of welcome. A land of industrial tradition, Wallonia has forged its identity through immigration. It has a young, internationally mobile population. The universities and colleges, present in world rankings, are distinguished by a very high proportion of foreign students. Sense of sharing, Accessibility, Technological know-how, and Quality of life Type: | 30 | 3 | 19 | 31 |
 | Astellas Gene Therapies Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina. Content is intended for a US audience. gene therapy and biotechnology Type: | 3 | 0 | 2 | 403 |
 | Pennsylvania Department of Community & Economic Development Satisfaction comes through both work and quality of life – and Pennsylvania delivers it all. The Department of Community and Economic Development’s mission is to encourage the shared prosperity of all Pennsylvanians by supporting good stewardship and sustainable development initiatives across our commonwealth. With a keen eye toward diversity and inclusiveness, we act as advisors and advocates, providing strategic technical assistance, training, and financial resources to help our communities and industries flourish. community and economic development, expansion and relocation, small business development centers, trade and investment, expertise, network of domestic and international partners, business resources and services, business assistance, financial … | 29 | 3 | 26 | 484 |
 | Poseida Therapeutics, Inc. The Capacity to Cure Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes investigational allogeneic CAR-T cell therapies for both solid tumors and hematologic cancers as well as investigational in vivo genetic medicines that address patient populations with high unmet medical need. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. … Type: | 3 | 0 | 3 | 349 |
 | MindMed MindMed is a clinical-stage biopharma company developing novel products to treat brain health disorders MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the … Type: | 4 | 0 | 3 | 102 |
 | EveryLife Foundation for Rare Diseases The EveryLife Foundation for Rare Diseases educates, supports and amplifies the voice of rare disease patient advocates. We empower the rare disease patient community to advocate for impactful, science-driven legislation and policy that advances the equitable development of and access to lifesaving diagnoses, treatments, and cures. Advocacy, Patient Engagment, Rare Diseases, and Public Policy Type: | 15 | 0 | 14 | 61 |
 | Sonata Therapeutics Sonata Therapeutics is a new, Boston-based Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact. Our employees are exceptionally passionate, accountable, collaborative, and innovative. Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences … Type: | 7 | 0 | 7 | 44 |
 | Daré Bioscience, Inc. Daring to be different Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women. Vaginal drug delivery is often the optimum delivery approach to achieve these objectives, and IVR technology has become one of our preferred investigational platforms. Our portfolio features innovative IVR technologies including our non-hormonal contraceptive Ovaprene®, which we believe has the potential to disrupt … Type: | 6 | 0 | 5 | 26 |
 | Hesperos Inc. The Human-on-a-Chip Company Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the … Type: | 2 | 0 | 2 | 62 |
 | NASDA - National Association of State Departments of Agriculture Advancing agriculture in the states. Founded in 1916, NASDA is a nonpartisan, nonprofit association which represents the elected and appointed commissioners, secretaries, and directors of the departments of agriculture in all fifty states and four U.S. territories. NASDA grows and enhances agriculture by forging partnerships and creating consensus to achieve sound policy outcomes between state departments of agriculture, the federal government, and stakeholders. To learn more about NASDA, please visit www.nasda.org. Type: | 2 | 1 | 2 | 269 |
 | DIVA Expertise [Automatic translation follows] DEEP INNOVATION on adipose tissue. Research partner from the cell to Humans D.I.V.A. Expertise is a consulting, strategy and development company in scientific research in the fields of Health, Nutrition, Cosmetics and Aesthetics. Its objectives are to support manufacturers in the structuring, organization and development of their research in order to optimize its costs, deadlines and results. Personalized support from our experts boosts the R&D process of a product by promoting Creativity, Innovation and Collaboration. Its core expertise is targeted on the biology of fatty tissue called adipose, recognized as an endocrine organ with a fundamental and … Type: | 7 | 1 | 4 | 9 |
 | Envisagenics Artificial Intelligence, High Performance Computing, and RNA sequencing data to find cures faster than ever before. Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. We focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be … Type: | 14 | 2 | 12 | 48 |
 | Blueprint Medicines Striving to improve and extend patients' lives Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our … Type: | 10 | 1 | 6 | 729 |
 | PSC Biotech Corporation Your Global Life Science Solutions Partner Founded in 1996, PSC Biotech Corporation was created with the vision of providing life science companies unmatched support. PSC Biotech Corporation serves 1000 clients in more than 35 countries worldwide through professional services consulting, cloud-based software solutions, pharmaceuticals contract manufacturing, life science investment consulting, and metrology services. PSC Biotech Corporation has three unique divisions within the parent company – each representing one of our areas of expertise: PSC Biotech, PSC Software, and BioTechniqueTM. Additionally, PSC Asia and PSC Biotech Ltd represent PSC Biotech Corporation in Asia and Europe, respectively. Together, these divisions enable us … Type: | 1 | 0 | 1 | 539 |
 | BigHat Biosciences BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids … Type: | 19 | 0 | 19 | 107 |
 | Biofourmis Revolutionizing the Delivery of Healthcare. Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science … Type: | 34 | 3 | 31 | 393 |
 | Poolbeg Pharma plc Committed to the development and commercialisation of innovative medicines. Ticker: POLB Poolbeg Pharma plc is committed to the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, with a growing emphasis on rare and orphan diseases. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to fund the development of its robust pipeline of innovative products, thereby driving significant value creation. Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value. The team has been strengthened by the appointment of three former members … Type: | 6 | 0 | 6 | 15 |
 | Locus Biosciences, Inc. Locus Biosciences, Inc. is a biotechnology company that develops precision, engineered bacteriophage products. Locus Biosciences is a clinical-stage biotechnology company developing engineered bacteriophage products to address critical unmet medical needs in bacterial infections and immunology. The LOCUS platform combines predictive artificial intelligence and automated robotics to deliver optimized precision phage therapies that specifically kill target pathogens while leaving non-target bacteria (i.e., the rest of the patient’s microbiome) unaffected. Locus has strong backing from partners, having signed contracts with BARDA and CARB-X. The company recently completed the open-label portion of a Phase 2 trial assessing LBP-EC01 for the treatment of uncomplicated … Type: | 8 | 4 | 4 | 61 |
 | Medika Life Make informed choices about your health. Our MOBILIZETM platform highlights issues affecting global healthcare. Medika Life is an online health information platform dedicated to bringing scientifically-validated and actionable health information to the world. We focus on promoting the voices of healthcare practitioners from within the industry. Our MOBILIZETM Medicine platform addresses global and local issues affecting the delivery of basic healthcare to all communities. We are outspoken in terms of equality, both within the industry - from a professional perspective - and in the delivery and accessibility of services. Our articles, mostly written by colleagues across the medical spectrum, are … Type: | 5 | 0 | 2 | 8 |
 | Genialis The RNA Biomarker Company. Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data. Data Fusion, Machine Learning, Biomedical Data Analysis, Omics Data Integration, Precision Medicine, Software Development, Data Visualization, Gene Signature, and Predictive Biomarker Type: | 16 | 0 | 15 | 41 |
 | Altoida, Inc. Pioneering digital #biomarkers of neurological disease using augmented reality and machine learning. Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster and more sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine. Digital Health, … Type: | 14 | 1 | 9 | 42 |
 | Medable, Inc The leading global platform for decentralized clinical trials. Medable's mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Our vision is to accelerate the path to human discovery and medical cures. We are passionate about driving innovation and empowering consumers. We are proactive, collaborative, self-motivated learners, committed, bold and tenacious. We are dedicated … Type: | 27 | 1 | 22 | 361 |
 | Qorvis A global advisory and strategic communications firm at the nexus of influence and capital Qorvis is a global advisory and strategic communications firm headquartered in Washington, D.C., with primary offices in Geneva and Dubai. Standing at the nexus of influence and capital, we leverage our rich 20-year history to help the world’s most recognizable brands navigate the headwinds of a rapidly changing stakeholder economy and anticipate what’s next in the increasingly volatile geopolitical landscape. We have the reach and resources to deliver clear and actionable strategies to optimize brand performance, accelerate growth, secure capital and influence outcomes in the markets … Type: | 11 | 0 | 9 | 46 |
 | Business France (Invest in France) Business France and its partners: promoting and supporting foreign investment in France Creators of business opportunities, throughout the world 🌍 International development is key to the development of your business. What if a meeting with Business France was what you needed to give your projects a new dimension? Our three flagship professions all have one thing in common: boosting you on the global stage! To fast-track exports, we make the daily lives of entrepreneurs easier by providing them with the power of our network. To generate investments and employment in France, we promote the economic attractiveness of our … Type: | 153 | 12 | 150 | 161 |
 | Evaxion Biotech A/S AI-ImmunologyTM Powered Vaccines Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-ImmunologyTM. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-ImmunologyTM, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-ImmunologyTM … Type: | 2 | 0 | 2 | 60 |
 | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs The trade association giving a bigger voice to small and mid-sized innovative health technology companies in Europe For 15 years, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) has been the voice of small to mid-sized health technology companies in Europe. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through innovative therapies and medical technology. EUCOPE’s members – who represent over 2600+ innovative companies directly or via associations – are researching, designing, developing, supplying, manufacturing, and deploying the next … Type: | 19 | 4 | 14 | 20 |
 | Immunic Therapeutics Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/ Type: | 3 | 0 | 3 | 84 |
 | Kineta KA (Nasdaq) Developing next-generation immunotherapies for cancer patients! Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience | 7 | 0 | 4 | 29 |
 | Varda Space Industries Expanding the economic bounds of humankind. Low Earth orbit is open for business. Varda is accelerating the development of commercial space infrastructure, from in-orbit pharmaceutical processing to reliable and economical reentry capsules. Reusable rockets have lowered the cost of access to space and opened up a range of in-space activities. Now that access to space is cheap, it’s what we do there that counts. From new, life-saving pharmaceuticals to more powerful fiber optic cables, there is a world of products used on Earth today that can only be manufactured in space. Varda is accelerating innovation in the orbital economy and … Type: | 3 | 1 | 3 | 115 |
 | Oncopole [Automatic translation follows] Research, development and investment hub to accelerate cancer research in Quebec Research, development and investment hub to accelerate the fight against cancer. Type: | 9 | 2 | 7 | 16 |
 | MTPConnect We are Australia's Life Sciences Innovation Accelerator. We are Australia's Life Sciences Innovation Accelerator championing the continuing growth of Australia's vibrant medical products sector. Connect with our newsletter: https://www.mtpconnect.org.au/newsletter Subscribe to our podcast: https://podcasts.apple.com/au/podcast/the-mtpconnect-podcast/id1453637211 Medical technology, Biotechnology, Pharmaceutical, Collaboration, and Commercialisation Type: | 22 | 1 | 21 | 47 |
 | Labiotech.eu The leading digital media covering global biotech innovation Labiotech.eu is the leading digital media covering the global biotech industry. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Join them now and enjoy reading our stories! "We are building the Next Generation of Digital Media for Biotech" Philip & Joachim, Founders of Labiotech.eu Biotechnology, Life science, News, and Media Type: | 50 | 7 | 40 | 15 |
 | CCI Midi-Pyrénées [Automatic translation follows] A network connected to its time, to businesses, to its missions, to its partners and to the natural elements AIR-MER-TERRE The CCI Midi-Pyrénées acts for the economic development of the region, alongside businesses. A place of consultation and coordination of the eight territorial chambers, the CCI Midi-Pyrénées carries out specific joint actions with them. The consular network has developed multiple services for businesses, from creation to transfer or transmission. It is also a contact of choice for students and workers looking for training. In 2015, the network of CCIs of Midi-Pyrénées supported 140 businesses in their energy … Type: | 112 | 36 | 78 | 115 |
 | GLG The world's insight network GLG is the world’s largest insight network. We connect decision makers to the right experts so they can act with the confidence that comes from true clarity and have what it takes to get ahead. Our network of experts is the world’s largest source of first-hand expertise, and we recruit hundreds of new experts every day. We bring the power of insight to every great professional decision. Visit GLGinsights.com. For information regarding GLG’s practices with respect to personal information, please visit our privacy policy at https://glginsights.com/privacy-policy/ Professional Learning, Phone Consultations, Meetings, Roundtables, Site Visits, Strategic Projects, … Type: | 18 | 2 | 12 | 11,380 |
 | Damon Runyon Cancer Research Foundation We fund high-risk, high-reward cancer research. We identify & enable young scientists who are brilliant, brave and bold. To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. The Foundation supports emerging leaders who have great potential to achieve breakthroughs in how we diagnose, treat and prevent cancer. To date, the Foundation has invested nearly $395 million in cancer research, supporting over 3,825 doctors and researchers. Its alumni include 13 Nobel Laureates and 86 members of the National Academy of Science (the science ‘Hall of Fame’). For more, visit … Type: | 13 | 2 | 12 | 34 |
 | Microbiotica Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair. It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche … Type: | 6 | 2 | 2 | 49 |
 | Oregon Bioscience Association Advocate. Cultivate. Educate. Doing all things bio in the Pacific Northwest. Oregon Bioscience Association (@OregonBio) members are involved in cutting edge research and development of innovative health care, agricultural and environmental bio technologies. Our corporate members range from entrepreneurial start ups developing a first product to large multinationals. We also represent the state’s biotech research institutions, service providers to the industry and academic centers of learning. A unified voice for the Oregon bioscience community the Oregon Bio: * Represents the bioscience research to commercialization process * Helps to accelerate the growth of the biosciences industry in all parts of Oregon … Type: | 14 | 0 | 14 | 19 |
 | Amyris Make Good. No Compromise.® Amyris is a vertically integrated, synthetic biology company that creates sustainable, market-ready ingredients utilizing proprietary advanced precision fermentation technology and world-class platforms. Leveraging two decades of experience, Amyris collaborates with companies to co-create innovative ingredients at unprecedented speed and scale. This enables partners to deliver products with differentiated performance that meet sustainability and economic objectives. Its renewable and traceable ingredients are included in over 20,000 products from the world’s top brands, reaching more than 300 million consumers. For more information, please visit http://www.amyris.com. synthetic biology, specialty renewable chemicals, biotech, clean beauty, sweetener, CBD, natural ingredients, sustainability, … Type: | 16 | 1 | 15 | 1,059 |
 | Novaxia Your service provider in histology Since 1996, Novaxia is an independent laboratory offering customized services in histology. Whether you are a private or public research center, Novaxia accompanies you in your development projects. We work according to Good Laboratory Practices (G.L.P. Accreditation by the relevant French authority : ANSM). The range of services offered extend beyond classical histology, since today Novaxia offers services such as immunohistochemistry (IHC) and slide digitization. Our first priority is to put our knowledge and skills at your disposal. We want to understand your scientific question to ensure that we fully meet all of your expectations. … | 3 | 0 | 3 | 19 |
 | iLoF Using AI and Photonics to enable a new era of personalized, precision medicine. iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development. Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported … Type: | 27 | 4 | 21 | 36 |
 | Transgene Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IOTM and myvac® Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer. | 26 | 14 | 11 | 209 |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 41 | 16 | 33 | 70 |
 | The Sophia Consulting Firm Amplifying Scientific Innovation® The Sophia Consulting Firm LLC is an AI-enabled global thought leadership platform focused on Amplifying Scientific Innovation®. By leveraging GenAI, automation, streamlined workflows, and data analytics, the consultancy empowers innovators and lifelong learners with the latest expert opinions on trending topics. To further drive impactful conversations and knowledge sharing, the consultancy connects top-tier speakers with global audiences and leverage its legacy multichannel platform, consisting of the flagship video podcast, white papers, books, blogs, and articles in leading media outlets. For more information, please visit www.sophiaconsultingfirm.com scientific communications, oncology, women's health, regenerative medicine, books, executive leadership, STEM, leadership, … Type: | 11 | 1 | 6 | 4 |
 | Nuclera Bring rapid protein access to your benchtop with eProtein Discovery At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein DiscoveryTM system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology … Type: | 7 | 1 | 4 | 127 |
 | Kelonia Therapeutics Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines. Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal … Type: | 2 | 1 | 1 | 59 |
 | Global Coalition on Aging We’re the world’s leading business voice on aging-related policy and strategy. The Global Coalition on Aging (GCOA) aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. Through research, public policy analysis, advocacy and strategic communications, GCOA is advancing innovative policy and market solutions and working to ensure global aging is a path to health, productivity, and economic growth. Type: | 7 | 2 | 6 | 11 |
 | AbilityPharma Ability Pharmaceuticals is a clinical-stage biopharmaceutical company committed to develop first-in-class therapies that address unmet medical needs in the oncology space. AbilityPharma's is currently conducting, with ABTL0812, the most advanced asset, an international multi-center, double-blind, placebo-controlled phase 2b clinical trial in patients with metastatic pancreatic cancer to investigate ABTL0812 as first-lin therapy in combination with FOLFIRINOX chemotherapy. The study includes reference centers in Spain, France, United States and Israel. ABTL0812 has finished with very positive results a phase 2a clinical trial as first-line therapy in endometrial cancer and in squamous NSCLC in combination with paclitaxel and carboplatin. The study included … Type: | 3 | 0 | 3 | 23 |
 | Equilar The Trusted Source for Executive Intelligence Equilar is the leading provider of executive intelligence solutions. The company’s expertise in relationship intelligence drives state-of-the-art business development and CRM applications, board and executive recruitment, and compensation and governance strategies. Equilar integrates its extensive database of executive profiles with natural language processing and machine learning AI to enable real-time relationship analytics and targeted outreach for its global clients. Equilar's commitment to excellence has made it the go-to solution for over 1,000 companies, including 75% of the Fortune 500, top PE/VC firms, and leading professional services entities. Learn more at www.equilar.com. Human Resources, Shareholder … Type: | 42 | 4 | 38 | 135 |
 | Sunstein LLP Intellectual property law is continuously evolving. Sunstein is at the forefront. Sunstein LLP is a boutique Intellectual Property firm with a 40-year history of success and expertise in all areas of IP law including litigation, patent and trademark prosecution, intellectual property portfolio development and business transactions. IP law is rapidly evolving and Sunstein has been at the forefront of these changes. Law firm, IP firm, Intellectual Property, Patent, Copyright, and Trademark | 5 | 0 | 5 | 71 |
 | Virginia Bio connecting the life sciences community The Virginia Biotechnology Association (Virginia Bio), formed in 1992, is the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia. More than 200 member organizations have joined forces to make Virginia Bio an effective advocate for the biopharmaceutical and device industries before federal, state and local policy-makers. Virginia Bio is the official state affiliate of the Biotechnology Industry Organization (BIO), in Washington, D.C. Professional service firms, research labs and all manner of bioscience companies are welcome to participate. To join Virginia Bio, please visit us at www.vabio.org, on X … Type: | 5 | 0 | 4 | 15 |
 | Delaware Business Times Delaware's Must-Read Source for Business News. Using multiple platforms, Delaware Business Times provides timely, informative content to tens of thousands of decision-makers across the First State. From breaking news coverage and in-depth reporting to hosting networking and premier recognition events, Delaware Business Times has been connecting its readers with marketers for over a decade. Today Media is a multi-platform communications company providing content that attracts hundreds of thousands of loyal consumers each day and offers marketers advertising solutions in print, online, and in person. In addition to Delaware Business Times, Today Media publishes Delaware Today, Main Line Today, Westchester Magazine, … Type: | 2 | 0 | 2 | 8 |
 | Ginkgo Bioworks, Inc. Making biology easier to engineer. At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our … Type: | 15 | 9 | 1 | 1,130 |
 | NewYorkBIO NewYorkBIO supports the development and growth of New York State’s life science industry. NewYorkBIO supports the development and growth of New York State’s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. Type: | 31 | 1 | 31 | 16 |
 | Cytovance Biologics We are Cytovance Biologics, your responsive, reliable, and resourceful CDMO Partner. Welcome to Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage. From early needs like cell line development and strain selection to cGMP manufacturing for clinical … Type: | 2 | 0 | 0 | 212 |
 | Rabin Martin Together, we can make a lasting impact on global health – and your business. We’re Rabin Martin, a team of global health impact consultants. Driving better outcomes, access and equity – from strategy to execution. We design, develop and deliver effective solutions to unlock new markets and opportunities – creating creative ways for more people to access our client's medicines and vaccines, and generating support among key stakeholders. In today’s competitive and complex healthcare environment, leveraging Global Health expertise and partnerships, from strategy to execution, is a must-have in unlocking incremental growth. To do this, we bring together … Type: | 26 | 3 | 25 | 45 |
 | Corn Refiners Association Representing the corn wet milling industry and safe and affordable corn products since 1913. The Corn Refiners Association (CRA) is the national trade association representing the corn refining industry of the United States. CRA and its predecessors have served this important segment of American agribusiness since 1913. CRA advocates for science-based public policy and economically-sound decisions at the state, federal, and global levels. It approaches every new challenge with its members and their customers in mind, working to foster technological innovation, expand commercial opportunities, advance free trade, build the bioeconomy, and feed a hungry world. ABOUT THE INDUSTRY: Corn refiners … Type: | 1 | 0 | 0 | 24 |
 | LanzaTech Recycling carbon with biology Our way of life is built on carbon, from our fuel sources to the materials in our consumer products, but we need a more sustainable way to source it to protect the future of our planet. LanzaTech Global, Inc. is the carbon recycling company transforming waste carbon into sustainable raw materials for everyday products. Using its biorecycling technology, LanzaTech captures carbon-rich gases generated by energy-intensive industries at the source, preventing them from being emitted into the air. LanzaTech then gives that captured carbon a new life as a sustainable replacement for virgin fossil carbon in everything … Type: | 53 | 16 | 31 | 401 |
 | Illinois Biotechnology Innovation Organization (iBIO) To promote, connect and engage the life sciences community The Illinois Biotechnology Innovation Organization (iBIO) is a life sciences industry association of more than 500 members comprised of life sciences companies, universities, academic institutions, service providers and others dedicated to making Illinois and the surrounding Midwest one of the world’s top life sciences centers. We drive industry growth by creating a forum for the life sciences community to come together, educating the public and policy makers, influencing public policy and advancing the economic interests of the community. iBIO’s members range from small startups to global corporations. They work in the … Type: | 10 | 0 | 10 | 7 |
 | LaVoieHealthScience Team of specialized thinkers and executors in health and science innovation. Global Alliance with Omnicom PR Group LaVoieHealthScience provides strategic communications programs that integrate public and investor relations, marketing and communications to engage target stakeholders to create behavioral change. Our focus is on building value for health science innovations. Through our alliance with Omnicom Public Relations Group, we bring high-touch service with the global scale of 2,000 health expert consults across 100 countries. We help our clients create awareness, gain recognition and optimal value for their initiatives, technologies, products and businesses. Our expert team of investor relations and public relations … Type: | 5 | 0 | 4 | 12 |
 | Investment NSW Jobs. Skills. Investment. Investment NSW has a mandate to deliver on the NSW Government’s priorities to build a strong economy, attract local and international investment and help NSW businesses find new export markets. Working across key industries, our aim is to reinforce NSW’s global position as a safe and attractive place to do business and accelerate investment in priority sectors such as Net Zero, Technology, Advanced Manufacturing, International Education, Med Tech and Life Sciences, Agri-business and Defence and Aerospace. NSW is open for business. Large or small, international or domestic, now is the time for investors to capitalise on all … Type: | 10 | 4 | 6 | 196 |
 | BIOKET Bioeconomy Key Enabling Technologies platform Process & Technology innovations for biobased solutions to food, feed, chemicals, biomaterials and bioenergies Brussels, BELGIUM -- May 11-13, 2025 -- Biomass is a wonderful ressource to be transformed into chemicals, biobased materials, food and feed ingredients or energy. Still, adaptation and optimisation of transformation processes and technologies is a real challenge in order to valorise all biomass fraction in a circular approach. In the context of Industry 4.0, the circular economy and the need for an optimal valorization of renewable resources, BIOKET is the only European conference dedicated to bio-based technologies and processes. Innovative Processes, Biotechnology, Green Chemistry, Polymerisation, … Type: | 38 | 9 | 31 | 2 |
 | Vetter Pharma Your partner in aseptic filling and packaging We turn active ingredients into medicine. As one of the leading pharmaceutical service providers for the aseptic manufacture of injectable medicines, we are a global player – and a family business. Together with our 6,000 employees, we help improve the lives of people around the world. We combine tradition and innovation in a job that has meaning. Ravensburg is where our roots are. We make a significant contribution to reliably supplying patients with medicines from our state-of-the-art production sites in Europe and the United States. We work hand in hand with pharmaceutical and … Type: | 11 | 2 | 8 | 1,972 |
 | Women In Bio - Engage. Educate. Empower. Promoting Diversity and Inclusion for All Women in the Life Sciences Women In Bio is an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences. We aim to help women achieve the highest levels of leadership, influence and decision-making that they desire. Our primary focus is to provide women-to-women mentorship and leadership support through all stages of career development from bench to boardroom from academia to industry from first job to last from idea to entrepreneur Our members reflect the increasing spread of the life sciences. We belong to biotech and pharma companies, … Type: | 12 | 0 | 10 | 163 |
 | Greater Geneva Bern area (GGBa) We help international companies set up successful business operations in Western Switzerland. Greater Geneva Bern area (GGBa) is the official investment promotion agency for Western Switzerland. Its mission is to support foreign companies so that they can quickly establish and develop their operations in Western Switzerland. Its services include: providing information on business environment, taxation, operational costs and labor law; facilitating contacts with peer companies and industry groups; evaluating the best location for each company’s needs and finding suitable premises. This support is provided at no charge and on a confidential basis. Since its creation in 2010, GGBa has successfully … | 40 | 2 | 39 | 40 |
 | Montréal International The economic promotion agency for Greater Montréal. We are the official economic development and promotion agency for the Montréal region. Whatever projects you may be planning—investment, setting up or expansion—we are there to welcome you and help you succeed. Our services are free and confidential. Profiting from both its European and North American heritage, Greater Montréal is unique among North American metropolises in that it actively leverages creativity as an economic, social and cultural driving force. It is also the only metropolis to offer businesses an ideal combination of factors that are key to success: competitive operating costs, direct access … | 61 | 21 | 34 | 189 |
 | Life Sciences BC “Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care Type: | 32 | 5 | 25 | 31 |
 | City of Fishers SMART. VIBRANT. ENTREPRENEURIAL. The City of Fishers is a suburb of Indianapolis, Indiana, located in Hamilton County and was named #1 Place to Live in the US by Money Magazine in 2017. Under the leadership of Mayor Scott Fadness, Fishers is known as a smart, vibrant, and entrepreneurial city through its neighborhood development, dedication to supporting high-growth companies, and innovative city processes. With a population of 91,832 (2017), Fishers is one of the fastest growing communities in Indiana and has received national accolades for entrepreneurship, livability, and safety. Key community assets include: - A vibrant Nickel Plate District complete with … Type: | 6 | 1 | 4 | 287 |
Startup